Dr. Andrew John, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,168 | 104 | 52.9% |
| Consulting Fee | $1,500 | 1 | 36.6% |
| Education | $413.13 | 38 | 10.1% |
| Travel and Lodging | $15.42 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $1,515 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $320.03 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $262.91 | 8 | $0 (2024) |
| MAYNE PHARMA INC. | $261.44 | 21 | $0 (2022) |
| Amgen Inc. | $208.36 | 15 | $0 (2024) |
| UCB, Inc. | $157.99 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $154.39 | 6 | $0 (2022) |
| Taro Pharmaceuticals USA, Inc. | $141.66 | 34 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $134.84 | 5 | $0 (2022) |
| ABBVIE INC. | $128.90 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $479.62 | 20 | UCB, Inc. ($157.99) |
| 2023 | $402.87 | 20 | E.R. Squibb & Sons, L.L.C. ($155.57) |
| 2022 | $452.49 | 18 | Galderma Laboratories, L.P. ($154.39) |
| 2021 | $39.38 | 2 | Lilly USA, LLC ($27.12) |
| 2020 | $33.19 | 2 | MAYNE PHARMA INC. ($20.69) |
| 2019 | $379.00 | 25 | Mayne Pharma Inc. ($194.90) |
| 2018 | $526.02 | 43 | Taro Pharmaceuticals USA, Inc. ($141.66) |
| 2017 | $1,784 | 15 | Allergan Inc. ($1,515) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Immunology | ||||||
| 10/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $45.95 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 08/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Inflammation & Immunology | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Immunology | ||||||
| 06/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $129.16 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $47.99 | General |
| 05/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Immunology | ||||||
| 05/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Dermatology | ||||||
| 05/02/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $21.52 | General |
| 04/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Inflammation | ||||||
| 02/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Immunology | ||||||
| 02/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Immunology | ||||||
| 01/25/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.13 | General |
| 12/21/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Inflammation | ||||||
| 12/14/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: DERMATOLOGY | ||||||
| 12/01/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Inflammation | ||||||
| 11/30/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $16.67 | General |
| 11/10/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,913 | 5,841 | $428,472 | $184,558 |
| 2022 | 12 | 2,851 | 6,146 | $425,767 | $180,835 |
| 2021 | 13 | 2,572 | 5,328 | $375,076 | $164,518 |
| 2020 | 13 | 2,391 | 4,859 | $350,455 | $133,014 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,019 | 1,434 | $143,400 | $79,847 | 55.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 671 | 933 | $107,295 | $35,968 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 201 | $31,155 | $16,171 | 51.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 192 | 209 | $33,440 | $16,007 | 47.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 494 | 2,701 | $59,422 | $11,833 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 148 | 148 | $20,720 | $9,477 | 45.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 108 | 117 | $17,550 | $7,536 | 42.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $4,160 | $2,162 | 52.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $4,590 | $2,120 | 46.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 41 | $2,870 | $1,414 | 49.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,220 | $1,205 | 54.3% |
| 10040 | Acne surgery | Office | 2023 | 11 | 11 | $1,650 | $818.15 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 992 | 1,440 | $143,935 | $78,920 | 54.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 655 | 924 | $106,260 | $37,523 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 259 | 259 | $36,260 | $17,057 | 47.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 522 | 3,069 | $67,518 | $13,722 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 121 | 141 | $22,499 | $10,077 | 44.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 116 | 121 | $18,150 | $7,994 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 71 | $11,005 | $6,323 | 57.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 22 | 23 | $5,980 | $2,985 | 49.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 16 | 16 | $4,480 | $1,907 | 42.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 19 | 19 | $3,990 | $1,731 | 43.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 44 | 47 | $3,290 | $1,682 | 51.1% |
| 10040 | Acne surgery | Office | 2022 | 16 | 16 | $2,400 | $914.50 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 916 | 1,325 | $132,500 | $76,153 | 57.5% |
About Dr. Andrew John, M.D
Dr. Andrew John, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Edmond, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609193614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew John, M.D has received a total of $4,096 in payments from pharmaceutical and medical device companies, with $479.62 received in 2024. These payments were reported across 145 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,168).
As a Medicare-enrolled provider, John has provided services to 10,727 Medicare beneficiaries, totaling 22,174 services with total Medicare billing of $662,926. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Edmond, OK
- Active Since 04/29/2010
- Last Updated 04/13/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1609193614
Products in Payments
- RHOFADE (Drug) $1,515
- Sotyktu (Drug) $262.91
- Tremfya (Drug) $247.39
- DORYX (Drug) $215.59
- Otezla (Drug) $208.36
- Bimzelx (Biological) $157.99
- COSENTYX (Biological) $134.84
- DUPIXENT (Drug) $116.33
- OPZELURA (Drug) $99.68
- SILIQ (Drug) $92.83
- DUPIXENT DUPILUMAB INJECTION (Biological) $89.52
- ILUMYA (Biological) $69.79
- Humira (Biological) $66.41
- EPSOLAY (Drug) $64.60
- TREMFYA (Drug) $55.34
- HALOG (Halcinonide Cream, USP) 0.1% (Drug) $53.34
- TALTZ (Drug) $53.15
- RINVOQ (Biological) $48.94
- TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) $42.24
- CIBINQO (Drug) $25.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Edmond
Dr. Shea Charbeneau, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $13,355
Mr. Chad Knight, D.p.m, D.P.M
Student in an Organized Health Care Education/Training Program — Payments: $7,378
Heather Wheeler, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $5,768
Dr. Tiffany Mao, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,313
Jennifer Li, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,840
Jeremy Edwards, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $1,361